SRPT Sarepta Therapeutics
- 123.650
- +6.530+5.58%
Sarepta Therapeutics News
Sarepta Therapeutics | S-8 POS: S-8 POS
Sarepta Therapeutics | S-8 POS: S-8 POS
Sarepta Therapeutics | S-8 POS: S-8 POS
Sarepta Therapeutics | S-8 POS: S-8 POS
Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Wigzell Hans Lennart Rudolf
Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Arif Bilal
Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rodino-Klapac Louise
Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Boor Kathryn Jean
Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Brown Ryan Edward
Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Estepan Ian Michael
Sarepta Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Sarepta Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Estepan Ian Michael
Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Mayo Stephen
Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Brown Ryan Edward
Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Arif Bilal
Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rodino-Klapac Louise
Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Estepan Ian Michael
Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Boor Kathryn Jean
Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director BEHRENS M KATHLEEN
Analysis
Price Target
No Data
